CARA - Cara Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CARA (1346830)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
16 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P3+13+9+34+21
S8-6-16-34-50

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-11-01
CARAChalmers Derek TPres, CEOS - Sale+OE$12.66-16,0001,086,292-1%-$202,560
2017-08-04
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$15.00-3,000117,000-3%-$45,000
D
2017-07-14
CARAChalmers Derek TPres, CEOS - Sale+OE$15.05-25,0001,082,292-2%-$376,250
2017-07-14
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$15.00-3,000120,000-2%-$45,000
2017-06-29
CARASlagel DeanDirS - Sale$25.87-250,0001,064,338-19%-$6,468,564
2017-03-31
CARARho Ventures VI LP10%P - Purchase$18.19+500,0003,568,057+16%+$9,095,700-3-1-19
2016-04-20
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$9.00-6,000123,000-5%-$54,000-9-18-26-2
M
2016-03-16
CARAVogelbaum MartinDirP - Purchase$4.87+400,0003,068,057+15%+$1,949,203+21+14+60+21
M
2016-03-16
CARARho Ventures VI LP10%P - Purchase$4.87+400,0003,068,057+15%+$1,949,203+21+14+60+21
M
2016-02-01
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$9.04-6,000129,000-4%-$54,250-1-19-37-35
2016-01-26
CARALewis Michael EChief Scientific AdvisorS - Sale$10.93-7,262314,988-2%-$79,374-7-14-30-40
AM
2015-12-31
CARASlagel DeanDirS - Sale$17.01-44,0001,314,338-3%-$748,312-16-19-47-62
2016-01-06
CARAChalmers Derek TPres, CEOS - Sale$17.22-12,5001,087,292-1%-$215,250-1-22-42-59
2016-01-04
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$16.80-6,000135,000-4%-$100,800-4-24-52-76
M
2015-12-31
CARASlagel DeanDirS - Sale$17.01-44,0001,314,338-3%-$748,312-4-24-52-76
2015-12-01
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$16.21-6,000141,000-4%-$97,260-2+9+14-54

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top